HOUSTON (Feb. 4, 2014). With
first patients enrolled, OrthoAccel Technologies, Inc. announces
the start of a groundbreaking clinical trial that evaluates the effect of
AcceleDent on orthodontic tooth movement with aligners.
Manufactured by OrthoAccel, AcceleDent is the only FDA-cleared, Class II
medical device that speeds up orthodontic treatment by as much as 50 percent.
Conducted at the University
of Florida College of Dentistry, the prospective randomized controlled
trial follows patients for 12 weeks during their clear aligner treatment with
AcceleDent. The trial’s principal investigator, Timothy Wheeler, D.M.D., Ph.D.,
is a distinguished researcher of orthodontic treatment with clear aligners.
“The purpose of this clinical
trial is to evaluate how pulsatile forces produced through AcceleDent’s
SoftPulse Technology enable teeth to move faster,” said Wheeler who
is a professor at the University of Florida College of Dentistry.
“AcceleDent is such a groundbreaking innovation that there’s a lot of interest
in this study among orthodontists who want clinical evidence showing the
product’s potential benefits when used with clear aligners – faster tooth
movement and reduced pain.”
First introduced in the U.S. in
2012, AcceleDent’s technology was developed in part by Dr. Jeremy Mao,
co-director of the Center for Craniofacial Regeneration at Columbia University
College of Dental Medicine in New York. Mao’s pioneering work in the early
2000s, which was initially conducted while he was a faculty member at the
University of Illinois, Chicago, was paramount in establishing the therapeutic
effect of pulsatile forces in accelerating bone modeling and remodeling in the
craniofacial region.
With many of the nation’s leading
orthodontists prescribing AcceleDent to their patients, AcceleDent is now
available in over 1,000 orthodontic locations throughout the U.S.
“As the sole provider of a
noninvasive, FDA-cleared medical device that speeds up orthodontic treatment, we
recognize our responsibility to support orthodontists by continuing to provide
clinical evidence confirming AcceleDent’s claims of accelerating orthodontic
tooth movement safely and gently,” said Michael K. Lowe, president and CEO of
OrthoAccel.
Orthodontists and staff members
interested in learning more about AcceleDent, or how to offer the technology at
their practice, can locate an OrthoAccel sales representative at
AcceleDent.com/orthodontists or call 866-866-4919.